SlideShare ist ein Scribd-Unternehmen logo
1 von 32
Downloaden Sie, um offline zu lesen
YATIKA KOHLI PH.D.
DIRECTOR, RA BIOPHARMACEUTICALS.
APOTEX INC.
PREPARING FOR YOUR
REGULATORY SUBMISSION -
TIPS FOR EFFECTIVE
REGULATORY STRATEGY
1 CAPRA EDUCATION DAY, June 4
2014
Disclaimer
CAPRA EDUCATION DAY, June 4 2014
2
The information and views expressed in this
presentation are my personal views, and may
not be understood or quoted as being made
on behalf of Apotex
Elements of Successful Regulatory Submission
Elements of
successful
Regulatory
submission
Close interaction with
project team and
following project
plans through out
development process
Generation of
submission ready
documents in
conjunction with
completion of
development
activities
Creation of one page
registration plan with
defined contact points
with concerned health
authorities
Creation of regulatory
strategy to align
regulatory activities
with Business
objectives
Application of
applicable guidelines
throughout the
development process
Use of standard
templates for
document creation,
review and tracking
3 CAPRA EDUCATION DAY, June 4 2014
Elements of Successful Regulatory Submission
Elements
of
successful
Regulatory
submission
Close interaction
with project team
and following
project plans
through out
development
process
Generation of
submission ready
documents in
conjunction with
completion of
development
activities
Creation of one
page registration
plan with defined
contact points with
concerned health
authorities
Creation of
regulatory
strategy to align
regulatory
activities with
Business
objectives
Application of
applicable
guidelines
throughout the
development
process
Use of standard
templates for
document creation,
review and
tracking
4 CAPRA EDUCATION DAY, June 4 2014
Creation of Regulatory Strategy
CAPRA EDUCATION DAY, June 4 2014
5
 Goal
 A well- developed and thought out plan that is
balanced, realistic and achievable to support the
organization’s mission and vision.
 Purpose
 To define the plan for developing the product with the goal of
obtaining regulatory approval in desired markets and lifecycle
management/maintenance post approval
 To establish GO/NO GO decision points
 To outline which path to take, with the background and the
rationale of why a specific path is selected or recommended
Creation of
regulatory
strategy to
align
regulatory
activities with
Business
objectives
Elements of Regulatory Strategy - 1/3
 Target Product Profile
 Targeted market(s)
 Targeted indication(s)
 Targeted Product composition, strengths, presentation
 Targeted shelf life and storage conditions
 Development program and Overall project timelines
 Regional vs. global development
 Regulatory requirements in the jurisdictions of interest
 Understanding of constraints, if any, to market the product in
country(ies) of interest
6 CAPRA EDUCATION DAY, June 4 2014
Creation of
regulatory
strategy to
align
regulatory
activities with
Business
objectives
Elements of Regulatory Strategy - 2/3
 Quality Aspects of development program
 Manufacturer – Who, where?
 Manufacturing Capabilities – small scale, commercial scale
 Timing of scale-up , if any
 Analytics – Applicable monographs (USP/Ph.Eur.);
Compendial methods; Who, where?
 Non-Clinical Program
 Regional vs. global development
 Regulatory requirements in the jurisdictions of interest
 Understanding of constraints, if any, to market the product in
country(ies) of interest
7 CAPRA EDUCATION DAY, June 4 2014
Creation of
regulatory
strategy to
align
regulatory
activities with
Business
objectives
Elements of Regulatory Strategy - 3/3
 Clinical program
 Regional vs. global development
 Phase(s) and # of clinical trials
 Single vs. multi-country / Single vs. multicenter study(ies)
 Country(ies) where the study(ies) will be conducted
 Type of clinical trial application - CTA/IND/IMPD
 High level study design and sample size
 Comparative vs. non-comparative
 Comparator – placebo/standard of care/reference product
8 CAPRA EDUCATION DAY, June 4 2014
Creation of
regulatory
strategy to
align
regulatory
activities with
Business
objectives
Influences on Regulatory Strategy
CAPRA EDUCATION DAY, June 4 2014
9
Regulatory Strategy
Competitive Products
Technology
Patients
Patient Advocacy Groups
Etc.
Regulatory Affairs
Product Development
Manufacturing
Etc.
Regulatory Authorities
Guidelines
Standards Organizations
Etc.
External Influences
Regulatory Influences
Internal Influences
Creation of
regulatory
strategy to
align
regulatory
activities with
Business
objectives
CAPRA EDUCATION DAY, June 4 2014
10
 Market objectives (e.g., desired claims and markets)
 Where is the company positioned in the space – leader, fast follower,
me-too?
 The definition of success
 Business drivers
 Degree of development work already completed
 Previous experiences with similar products
 Depth of understanding of technology and mechanisms of action
 Availability of resources (time, staff, expertise, and money)
 Interactions with other business/development projects
 Organization of the business (e.g., in-house vs. outsourced development
capability)
 Previous interactions with regulatory authorities
 Interaction with reimbursement strategy
 Planning evidence development
Regulatory Strategy – Internal Factors
Creation of
regulatory
strategy to
align
regulatory
activities with
Business
objectives
CAPRA EDUCATION DAY, June 4 2014
11
 The competitive landscape
 Trends in the domestic and global practice of medicine and standard of
care
 Regulatory or market concerns with particular product categories or
industry sectors
 Current and evolving regulatory environment – submissions
procedures, classification changes, evidence requirements, etc.
 Health economics of treatment/device and associated evidence and
comparative effectiveness expectations
 Current and evolving reimbursement policies
 Concerns over specific materials, components, treatment, etc.
 Prevalence and consequences of off-label use
Regulatory Strategy – External Factors
Creation of
regulatory
strategy to
align
regulatory
activities with
Business
objectives
 Competitive Landscape
 Who are the potential players? Real vs. potential
competitor(s)?
 Where are they located?
 Where are they with their respective development(s)?
 If ahead, how far ahead? If behind, how far behind?
 Regulatory Landscape and Framework?
 Regulatory environment – is it established, developing,
changing, evolving?
 New requirements/legislations/regulations available vs.
projected?
 Review requirements/ timing/ performance?
12 CAPRA EDUCATION DAY, June 4 2014
Regulatory Strategy – External Factors
Creation of
regulatory
strategy to
align
regulatory
activities with
Business
objectives
Elements of Successful Regulatory Submission
Elements
of
successful
Regulatory
submission
Close interaction
with project
team and
following project
plans through
out development
process
Generation of
submission
ready documents
in conjunction
with completion
of development
activities
Creation of one
page
registration plan
with defined
contact points
with concerned
health
authorities
Creation of
regulatory
strategy to align
regulatory
activities with
Business
objectives
Application of
applicable
guidelines
throughout the
development
process
Use of standard
templates for
document
creation, review
and tracking
13 CAPRA EDUCATION DAY, June 4 2014
One Page Registration Plan
CAPRA EDUCATION DAY, June 4 2014
14
 Goal
 A well- developed and thought out plan that describes the
specific steps and action required to successfully meet the
regulatory strategy objectives
 Purpose
 To have a high level understanding of the product development
program
 To define the milestones for health authorty(ies) contact during the
development program
 Common and consistent means of communication internally within
the project and functional teams
 Contains the specific elements required to assemble the regulatory
submission
Creation of one
page registration
plan with defined
contact points
with concerned
health
authorities
Regulatory Strategy – Points for Consideration
CAPRA EDUCATION DAY, June 4 2014
15
 Regulatory strategy is a living document – you
must EXPECT change
 Some examples:
Regulations evolve and change
Based on additional experience and/or information
agencies can change their view on the subject
New intelligence on similar product
Change in target label or markets
Pressure from patients, advocacy groups or media
Regulatory Strategy – Points for Consideration
CAPRA EDUCATION DAY, June 4 2014
16
 Definition of scope
 Defining and differentiating near-term and long-term
objectives
 Bridging elements and dependencies between the
business and regulatory strategies
 Keeping a focus on the end goal – clinical, product
quality, and business
 Identifying influencing elements (internal and external)
Understanding of different perspectives
coordinated into a meaningful, effective, resilient
guiding strategy
Regulatory Strategy – Execution and maintenance
CAPRA EDUCATION DAY, June 4 2014
17
 Successful execution depends on
 Detailed project plan
 Clear designation of organizational roles and
responsibilities
Internal resources (cross functional team
members, project lead, regulatory lead etc.)
External resources (consultants, CRO, Advisory
committee, Attorneys, Health Authorities)
 Effective support systems and procedures
 Effective communication and decision making
Elements of Successful Regulatory Submission
Elements
of
successful
Regulatory
submission
Close interaction
with project
team and
following project
plans through
out development
process
Generation of
submission ready
documents in
conjunction with
completion of
development
activities
Creation of one
page registration
plan with defined
contact points with
concerned health
authorities
Creation of
regulatory strategy
to align regulatory
activities with
Business objectives
Application of
applicable
guidelines
throughout the
development
process
Use of standard
templates for
document creation,
review and
tracking
18 CAPRA EDUCATION DAY, June 4 2014
Close Interaction with Project Team
 Purpose
 To inform and be informed of all project/program level
developments with respect to project timelines
 To identify, discuss, strategize on project/product specific
development issues
 To discuss and decide on the ongoing development pathway
 To develop internal and external communication strategy
 Elements
 Project Plans (timing)
 Project Charter (project deliverables)
 Budget/Resource requirements and constraints
19 CAPRA EDUCATION DAY, June 4 2014
Close interaction
with project team
and following
project plans
through out
development
process
Close Interaction with Project Team
 Project Plans
 Detailed, Integrated
 Identifies key activities, resources, timing
 Helps to define implement and control project
 Gantt charts and project management software are useful
 Started early
 Communicated
 Re-visited and revised as often as necessary
20 CAPRA EDUCATION DAY, June 4 2014
Close interaction
with project team
and following
project plans
through out
development
process
CAPRA EDUCATION DAY, June 4 2014
21
 Have the target clinical indication and anticipated labeling claims for your product been
outlined as part of a preliminary target product profile?
 Does your current program include consideration of anticipated future approval
requirements, e.g., endpoints, comparators, effect sizes, statistical criteria, based on
current approval precedents and ongoing competing clinical programs?
 Does your program include consideration of a changing regulatory environment,
including implementation of new legislation, guidances, or review requirements?
 Does your program proactively identify challenges or issues that may delay clinical
development and also define innovative solutions/approaches to circumvent these
challenges?
 Does your program leverage newly accepted development tools to reduce clinical
development time and expense and also proactively plan to maximize acceptance of
foreign data to access global markets?
 Does you program currently identify key opportunities to engage global regulatory
authorities and specify key data requirements to support these interactions?
 Does your program proactively eliminate development risk and uncertainty, while
maximizing the potential for commercial success?
Interaction with Project Team
– Questions to Consider Close interaction
with project team
and following
project plans
through out
development process
Elements of Successful Regulatory Submission
Elements
of
successful
Regulatory
submission
Close interaction
with project team
and following
project plans
through out
development
process
Generation of
submission ready
documents in
conjunction with
completion of
development
activities
Creation of one
page registration
plan with defined
contact points with
concerned health
authorities
Creation of
regulatory strategy
to align regulatory
activities with
Business objectives
Application of
applicable
guidelines
throughout the
development
process Use of
standard
templates for
document
creation,
review and
tracking
22 CAPRA EDUCATION DAY, June 4 2014
Document Standards and Practices
 Document Mapping
 Creation of document maps for the specific submission
(e.g. CTA/ IND (Phase I, II, III), CTD (Module 2-5)
 List of all documents categorized by sections of the submission under
consideration
 Identification of source, summary and support documents
 Use of standard formats and templates
 Develop standard format, word style guide conventions to be used
for regulatory submissions
 Communicate and train the project team members, authors, subject
matter experts (SME)
 Develop templates for all required sections of the intended
submission for clarity, completeness, standardization and
compliance with the requirements
23 CAPRA EDUCATION DAY, June 4 2014
Use of standard
templates for
document
creation, review
and tracking
Document Standards and Practices
 Review flows and timelines
 Creation and communication of review flows, expectations and
timelines
 Where will the document to review reside? Who will review
(internal/external reviewers), in what order and how long?
 Tracking
 Use of document maps for tracking of the documents in
planning, draft, review, completed
 Tracking of document progress in relation to the submission
requirements and project plans
 Communication to the project team for the status update
24 CAPRA EDUCATION DAY, June 4 2014
Use of standard
templates for
document
creation, review
and tracking
Elements of Successful Regulatory Submission
Elements
of
successful
Regulatory
submission
Close interaction
with project team
and following
project plans
through out
development
process
Generation of
submission ready
documents in
conjunction with
completion of
development
activities
Creation of one
page registration
plan with defined
contact points with
concerned health
authorities
Creation of
regulatory strategy
to align regulatory
activities with
Business objectives
Application of
applicable
guidelines
throughout the
development
process
Use of standard
templates for
document creation,
review and
tracking
25 CAPRA EDUCATION DAY, June 4 2014
Application of Guidelines
Purpose
 Significant streamlining in application processes
 Increased focus on effective and targeted compliance
activities
 More consistent application of strong but
proportionate enforcement activities
26 CAPRA EDUCATION DAY, June 4 2014
Application of
applicable
guidelines
throughout the
development
process
Application of Guidelines
 Know and understand the regulatory framework and
environment
 Find all applicable guidelines
 Global (ICH), Key/critical/important, regional/national
 Share and communicate the key consideration(s) to the project team
 Core to development
 Get involved and Start early – right first time
 Retrospective fix-ups take longer (time/cost/resource implications)
 Keep an eye out for the new regulations, directives/
legislations/ guidance
 Be active and get involved in providing comments to the draft
guidelines
 Key to successful submission, review and outcome
27 CAPRA EDUCATION DAY, June 4 2014
Application of
applicable
guidelines
throughout the
development
process
Elements of Successful Regulatory Submission
Elements
of
successful
Regulatory
submission
Close interaction
with project team
and following
project plans
through out
development
process
Generation of
submission ready
documents in
conjunction with
completion of
development
activities
Creation of one
page registration
plan with defined
contact points with
concerned health
authorities
Creation of
regulatory strategy
to align regulatory
activities with
Business objectives
Application of
applicable
guidelines
throughout the
development
process
Use of standard
templates for
document creation,
review and
tracking
28 CAPRA EDUCATION DAY, June 4 2014
Generation of Submission Ready Documents
29 CAPRA EDUCATION DAY, June 4 2014
Generation of
submission
ready documents
in conjunction
with completion
of development
activities
Generation of Submission Ready Documents
Global regulatory strategy does not mean identical
processes or documentation
 Obtain and manage documents during development
 Critical for timely application of guidelines/unique
or national requirements during development
 Important for introduction of standard practices for
document generation, review and tracking
 Key to successful submission, review and outcome
30 CAPRA EDUCATION DAY, June 4 2014
Generation of
submission
ready documents
in conjunction
with completion
of development
activities
Regulatory Submissions
Simplistic Success Formula
CAPRA EDUCATION DAY, June 4 2014
31
 Know the regulations, guidelines and specific
requirements
 Develop quality data using appropriate GMP, GCP,
GLP, QSR and QbD requirements
 Have well trained staff at all levels
 Build and maintain strong communication links with
the regulatory authority before and during the review
process
 Submit a well written dossier
 Plan for all post-approval commitments
CAPRA EDUCATION DAY, June 4 2014
32
Questions
?
Thank You

Weitere ähnliche Inhalte

Ähnlich wie 581ce1598f7df.pdf

What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...
What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...
What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...Nathan White, CPC
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014Dinesh T
 
Clinical evaluation and the latest 2016 guideline
Clinical evaluation and the latest 2016 guidelineClinical evaluation and the latest 2016 guideline
Clinical evaluation and the latest 2016 guidelineGRCTS
 
Critical Path Initiative Challenges
Critical  Path  Initiative  ChallengesCritical  Path  Initiative  Challenges
Critical Path Initiative ChallengesLandmark
 
Partnerships in Health Innovation: Expanding Paradigms of Private Profit and ...
Partnerships in Health Innovation: Expanding Paradigms of Private Profit and ...Partnerships in Health Innovation: Expanding Paradigms of Private Profit and ...
Partnerships in Health Innovation: Expanding Paradigms of Private Profit and ...Shift Health
 
INTRODUCTIONThe increasing discussion about rising healthcare co.docx
INTRODUCTIONThe increasing discussion about rising healthcare co.docxINTRODUCTIONThe increasing discussion about rising healthcare co.docx
INTRODUCTIONThe increasing discussion about rising healthcare co.docxvrickens
 
Huron Webinar_Government Pricing_A Top Priority for the Compliance Department...
Huron Webinar_Government Pricing_A Top Priority for the Compliance Department...Huron Webinar_Government Pricing_A Top Priority for the Compliance Department...
Huron Webinar_Government Pricing_A Top Priority for the Compliance Department...Clay Willis
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014Dinesh T
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014Dinesh T
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014Dinesh T
 
Does Innovation Pay DIA 2006
Does Innovation Pay DIA 2006Does Innovation Pay DIA 2006
Does Innovation Pay DIA 2006Neil Patel
 
Product Development Partnerships
Product Development PartnershipsProduct Development Partnerships
Product Development PartnershipsShift Health
 
Writing and enforcing effective so ps
Writing and enforcing effective so psWriting and enforcing effective so ps
Writing and enforcing effective so psGRCTS
 
Introduction to pManifold's Health Practice
Introduction to pManifold's Health PracticeIntroduction to pManifold's Health Practice
Introduction to pManifold's Health PracticepManifold
 
HFG Toolkit Presentation
HFG Toolkit PresentationHFG Toolkit Presentation
HFG Toolkit PresentationHFG Project
 
Highlights from ExL Pharma's 12th Investigator Initiated Trials
Highlights from ExL Pharma's 12th Investigator Initiated TrialsHighlights from ExL Pharma's 12th Investigator Initiated Trials
Highlights from ExL Pharma's 12th Investigator Initiated TrialsExL Pharma
 

Ähnlich wie 581ce1598f7df.pdf (20)

What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...
What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...
What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014
 
Clinical evaluation and the latest 2016 guideline
Clinical evaluation and the latest 2016 guidelineClinical evaluation and the latest 2016 guideline
Clinical evaluation and the latest 2016 guideline
 
Critical Path Initiative Challenges
Critical  Path  Initiative  ChallengesCritical  Path  Initiative  Challenges
Critical Path Initiative Challenges
 
NAAF Patient-Reported Outcomes Consortium
NAAF Patient-Reported Outcomes ConsortiumNAAF Patient-Reported Outcomes Consortium
NAAF Patient-Reported Outcomes Consortium
 
Partnerships in Health Innovation: Expanding Paradigms of Private Profit and ...
Partnerships in Health Innovation: Expanding Paradigms of Private Profit and ...Partnerships in Health Innovation: Expanding Paradigms of Private Profit and ...
Partnerships in Health Innovation: Expanding Paradigms of Private Profit and ...
 
INTRODUCTIONThe increasing discussion about rising healthcare co.docx
INTRODUCTIONThe increasing discussion about rising healthcare co.docxINTRODUCTIONThe increasing discussion about rising healthcare co.docx
INTRODUCTIONThe increasing discussion about rising healthcare co.docx
 
Huron Webinar_Government Pricing_A Top Priority for the Compliance Department...
Huron Webinar_Government Pricing_A Top Priority for the Compliance Department...Huron Webinar_Government Pricing_A Top Priority for the Compliance Department...
Huron Webinar_Government Pricing_A Top Priority for the Compliance Department...
 
James Profile
James ProfileJames Profile
James Profile
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014
 
Does Innovation Pay DIA 2006
Does Innovation Pay DIA 2006Does Innovation Pay DIA 2006
Does Innovation Pay DIA 2006
 
Product Development Partnerships
Product Development PartnershipsProduct Development Partnerships
Product Development Partnerships
 
Writing and enforcing effective so ps
Writing and enforcing effective so psWriting and enforcing effective so ps
Writing and enforcing effective so ps
 
Demonstrating ROI for Telehealth Programs
Demonstrating ROI for Telehealth ProgramsDemonstrating ROI for Telehealth Programs
Demonstrating ROI for Telehealth Programs
 
Introduction to pManifold's Health Practice
Introduction to pManifold's Health PracticeIntroduction to pManifold's Health Practice
Introduction to pManifold's Health Practice
 
HFG Toolkit Presentation
HFG Toolkit PresentationHFG Toolkit Presentation
HFG Toolkit Presentation
 
Highlights from ExL Pharma's 12th Investigator Initiated Trials
Highlights from ExL Pharma's 12th Investigator Initiated TrialsHighlights from ExL Pharma's 12th Investigator Initiated Trials
Highlights from ExL Pharma's 12th Investigator Initiated Trials
 
BOB WICK Resume November 2015
BOB WICK Resume November 2015BOB WICK Resume November 2015
BOB WICK Resume November 2015
 

Kürzlich hochgeladen

PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Monoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyMonoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyHasnat Tariq
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 

Kürzlich hochgeladen (20)

PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Monoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyMonoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technology
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 

581ce1598f7df.pdf

  • 1. YATIKA KOHLI PH.D. DIRECTOR, RA BIOPHARMACEUTICALS. APOTEX INC. PREPARING FOR YOUR REGULATORY SUBMISSION - TIPS FOR EFFECTIVE REGULATORY STRATEGY 1 CAPRA EDUCATION DAY, June 4 2014
  • 2. Disclaimer CAPRA EDUCATION DAY, June 4 2014 2 The information and views expressed in this presentation are my personal views, and may not be understood or quoted as being made on behalf of Apotex
  • 3. Elements of Successful Regulatory Submission Elements of successful Regulatory submission Close interaction with project team and following project plans through out development process Generation of submission ready documents in conjunction with completion of development activities Creation of one page registration plan with defined contact points with concerned health authorities Creation of regulatory strategy to align regulatory activities with Business objectives Application of applicable guidelines throughout the development process Use of standard templates for document creation, review and tracking 3 CAPRA EDUCATION DAY, June 4 2014
  • 4. Elements of Successful Regulatory Submission Elements of successful Regulatory submission Close interaction with project team and following project plans through out development process Generation of submission ready documents in conjunction with completion of development activities Creation of one page registration plan with defined contact points with concerned health authorities Creation of regulatory strategy to align regulatory activities with Business objectives Application of applicable guidelines throughout the development process Use of standard templates for document creation, review and tracking 4 CAPRA EDUCATION DAY, June 4 2014
  • 5. Creation of Regulatory Strategy CAPRA EDUCATION DAY, June 4 2014 5  Goal  A well- developed and thought out plan that is balanced, realistic and achievable to support the organization’s mission and vision.  Purpose  To define the plan for developing the product with the goal of obtaining regulatory approval in desired markets and lifecycle management/maintenance post approval  To establish GO/NO GO decision points  To outline which path to take, with the background and the rationale of why a specific path is selected or recommended Creation of regulatory strategy to align regulatory activities with Business objectives
  • 6. Elements of Regulatory Strategy - 1/3  Target Product Profile  Targeted market(s)  Targeted indication(s)  Targeted Product composition, strengths, presentation  Targeted shelf life and storage conditions  Development program and Overall project timelines  Regional vs. global development  Regulatory requirements in the jurisdictions of interest  Understanding of constraints, if any, to market the product in country(ies) of interest 6 CAPRA EDUCATION DAY, June 4 2014 Creation of regulatory strategy to align regulatory activities with Business objectives
  • 7. Elements of Regulatory Strategy - 2/3  Quality Aspects of development program  Manufacturer – Who, where?  Manufacturing Capabilities – small scale, commercial scale  Timing of scale-up , if any  Analytics – Applicable monographs (USP/Ph.Eur.); Compendial methods; Who, where?  Non-Clinical Program  Regional vs. global development  Regulatory requirements in the jurisdictions of interest  Understanding of constraints, if any, to market the product in country(ies) of interest 7 CAPRA EDUCATION DAY, June 4 2014 Creation of regulatory strategy to align regulatory activities with Business objectives
  • 8. Elements of Regulatory Strategy - 3/3  Clinical program  Regional vs. global development  Phase(s) and # of clinical trials  Single vs. multi-country / Single vs. multicenter study(ies)  Country(ies) where the study(ies) will be conducted  Type of clinical trial application - CTA/IND/IMPD  High level study design and sample size  Comparative vs. non-comparative  Comparator – placebo/standard of care/reference product 8 CAPRA EDUCATION DAY, June 4 2014 Creation of regulatory strategy to align regulatory activities with Business objectives
  • 9. Influences on Regulatory Strategy CAPRA EDUCATION DAY, June 4 2014 9 Regulatory Strategy Competitive Products Technology Patients Patient Advocacy Groups Etc. Regulatory Affairs Product Development Manufacturing Etc. Regulatory Authorities Guidelines Standards Organizations Etc. External Influences Regulatory Influences Internal Influences Creation of regulatory strategy to align regulatory activities with Business objectives
  • 10. CAPRA EDUCATION DAY, June 4 2014 10  Market objectives (e.g., desired claims and markets)  Where is the company positioned in the space – leader, fast follower, me-too?  The definition of success  Business drivers  Degree of development work already completed  Previous experiences with similar products  Depth of understanding of technology and mechanisms of action  Availability of resources (time, staff, expertise, and money)  Interactions with other business/development projects  Organization of the business (e.g., in-house vs. outsourced development capability)  Previous interactions with regulatory authorities  Interaction with reimbursement strategy  Planning evidence development Regulatory Strategy – Internal Factors Creation of regulatory strategy to align regulatory activities with Business objectives
  • 11. CAPRA EDUCATION DAY, June 4 2014 11  The competitive landscape  Trends in the domestic and global practice of medicine and standard of care  Regulatory or market concerns with particular product categories or industry sectors  Current and evolving regulatory environment – submissions procedures, classification changes, evidence requirements, etc.  Health economics of treatment/device and associated evidence and comparative effectiveness expectations  Current and evolving reimbursement policies  Concerns over specific materials, components, treatment, etc.  Prevalence and consequences of off-label use Regulatory Strategy – External Factors Creation of regulatory strategy to align regulatory activities with Business objectives
  • 12.  Competitive Landscape  Who are the potential players? Real vs. potential competitor(s)?  Where are they located?  Where are they with their respective development(s)?  If ahead, how far ahead? If behind, how far behind?  Regulatory Landscape and Framework?  Regulatory environment – is it established, developing, changing, evolving?  New requirements/legislations/regulations available vs. projected?  Review requirements/ timing/ performance? 12 CAPRA EDUCATION DAY, June 4 2014 Regulatory Strategy – External Factors Creation of regulatory strategy to align regulatory activities with Business objectives
  • 13. Elements of Successful Regulatory Submission Elements of successful Regulatory submission Close interaction with project team and following project plans through out development process Generation of submission ready documents in conjunction with completion of development activities Creation of one page registration plan with defined contact points with concerned health authorities Creation of regulatory strategy to align regulatory activities with Business objectives Application of applicable guidelines throughout the development process Use of standard templates for document creation, review and tracking 13 CAPRA EDUCATION DAY, June 4 2014
  • 14. One Page Registration Plan CAPRA EDUCATION DAY, June 4 2014 14  Goal  A well- developed and thought out plan that describes the specific steps and action required to successfully meet the regulatory strategy objectives  Purpose  To have a high level understanding of the product development program  To define the milestones for health authorty(ies) contact during the development program  Common and consistent means of communication internally within the project and functional teams  Contains the specific elements required to assemble the regulatory submission Creation of one page registration plan with defined contact points with concerned health authorities
  • 15. Regulatory Strategy – Points for Consideration CAPRA EDUCATION DAY, June 4 2014 15  Regulatory strategy is a living document – you must EXPECT change  Some examples: Regulations evolve and change Based on additional experience and/or information agencies can change their view on the subject New intelligence on similar product Change in target label or markets Pressure from patients, advocacy groups or media
  • 16. Regulatory Strategy – Points for Consideration CAPRA EDUCATION DAY, June 4 2014 16  Definition of scope  Defining and differentiating near-term and long-term objectives  Bridging elements and dependencies between the business and regulatory strategies  Keeping a focus on the end goal – clinical, product quality, and business  Identifying influencing elements (internal and external) Understanding of different perspectives coordinated into a meaningful, effective, resilient guiding strategy
  • 17. Regulatory Strategy – Execution and maintenance CAPRA EDUCATION DAY, June 4 2014 17  Successful execution depends on  Detailed project plan  Clear designation of organizational roles and responsibilities Internal resources (cross functional team members, project lead, regulatory lead etc.) External resources (consultants, CRO, Advisory committee, Attorneys, Health Authorities)  Effective support systems and procedures  Effective communication and decision making
  • 18. Elements of Successful Regulatory Submission Elements of successful Regulatory submission Close interaction with project team and following project plans through out development process Generation of submission ready documents in conjunction with completion of development activities Creation of one page registration plan with defined contact points with concerned health authorities Creation of regulatory strategy to align regulatory activities with Business objectives Application of applicable guidelines throughout the development process Use of standard templates for document creation, review and tracking 18 CAPRA EDUCATION DAY, June 4 2014
  • 19. Close Interaction with Project Team  Purpose  To inform and be informed of all project/program level developments with respect to project timelines  To identify, discuss, strategize on project/product specific development issues  To discuss and decide on the ongoing development pathway  To develop internal and external communication strategy  Elements  Project Plans (timing)  Project Charter (project deliverables)  Budget/Resource requirements and constraints 19 CAPRA EDUCATION DAY, June 4 2014 Close interaction with project team and following project plans through out development process
  • 20. Close Interaction with Project Team  Project Plans  Detailed, Integrated  Identifies key activities, resources, timing  Helps to define implement and control project  Gantt charts and project management software are useful  Started early  Communicated  Re-visited and revised as often as necessary 20 CAPRA EDUCATION DAY, June 4 2014 Close interaction with project team and following project plans through out development process
  • 21. CAPRA EDUCATION DAY, June 4 2014 21  Have the target clinical indication and anticipated labeling claims for your product been outlined as part of a preliminary target product profile?  Does your current program include consideration of anticipated future approval requirements, e.g., endpoints, comparators, effect sizes, statistical criteria, based on current approval precedents and ongoing competing clinical programs?  Does your program include consideration of a changing regulatory environment, including implementation of new legislation, guidances, or review requirements?  Does your program proactively identify challenges or issues that may delay clinical development and also define innovative solutions/approaches to circumvent these challenges?  Does your program leverage newly accepted development tools to reduce clinical development time and expense and also proactively plan to maximize acceptance of foreign data to access global markets?  Does you program currently identify key opportunities to engage global regulatory authorities and specify key data requirements to support these interactions?  Does your program proactively eliminate development risk and uncertainty, while maximizing the potential for commercial success? Interaction with Project Team – Questions to Consider Close interaction with project team and following project plans through out development process
  • 22. Elements of Successful Regulatory Submission Elements of successful Regulatory submission Close interaction with project team and following project plans through out development process Generation of submission ready documents in conjunction with completion of development activities Creation of one page registration plan with defined contact points with concerned health authorities Creation of regulatory strategy to align regulatory activities with Business objectives Application of applicable guidelines throughout the development process Use of standard templates for document creation, review and tracking 22 CAPRA EDUCATION DAY, June 4 2014
  • 23. Document Standards and Practices  Document Mapping  Creation of document maps for the specific submission (e.g. CTA/ IND (Phase I, II, III), CTD (Module 2-5)  List of all documents categorized by sections of the submission under consideration  Identification of source, summary and support documents  Use of standard formats and templates  Develop standard format, word style guide conventions to be used for regulatory submissions  Communicate and train the project team members, authors, subject matter experts (SME)  Develop templates for all required sections of the intended submission for clarity, completeness, standardization and compliance with the requirements 23 CAPRA EDUCATION DAY, June 4 2014 Use of standard templates for document creation, review and tracking
  • 24. Document Standards and Practices  Review flows and timelines  Creation and communication of review flows, expectations and timelines  Where will the document to review reside? Who will review (internal/external reviewers), in what order and how long?  Tracking  Use of document maps for tracking of the documents in planning, draft, review, completed  Tracking of document progress in relation to the submission requirements and project plans  Communication to the project team for the status update 24 CAPRA EDUCATION DAY, June 4 2014 Use of standard templates for document creation, review and tracking
  • 25. Elements of Successful Regulatory Submission Elements of successful Regulatory submission Close interaction with project team and following project plans through out development process Generation of submission ready documents in conjunction with completion of development activities Creation of one page registration plan with defined contact points with concerned health authorities Creation of regulatory strategy to align regulatory activities with Business objectives Application of applicable guidelines throughout the development process Use of standard templates for document creation, review and tracking 25 CAPRA EDUCATION DAY, June 4 2014
  • 26. Application of Guidelines Purpose  Significant streamlining in application processes  Increased focus on effective and targeted compliance activities  More consistent application of strong but proportionate enforcement activities 26 CAPRA EDUCATION DAY, June 4 2014 Application of applicable guidelines throughout the development process
  • 27. Application of Guidelines  Know and understand the regulatory framework and environment  Find all applicable guidelines  Global (ICH), Key/critical/important, regional/national  Share and communicate the key consideration(s) to the project team  Core to development  Get involved and Start early – right first time  Retrospective fix-ups take longer (time/cost/resource implications)  Keep an eye out for the new regulations, directives/ legislations/ guidance  Be active and get involved in providing comments to the draft guidelines  Key to successful submission, review and outcome 27 CAPRA EDUCATION DAY, June 4 2014 Application of applicable guidelines throughout the development process
  • 28. Elements of Successful Regulatory Submission Elements of successful Regulatory submission Close interaction with project team and following project plans through out development process Generation of submission ready documents in conjunction with completion of development activities Creation of one page registration plan with defined contact points with concerned health authorities Creation of regulatory strategy to align regulatory activities with Business objectives Application of applicable guidelines throughout the development process Use of standard templates for document creation, review and tracking 28 CAPRA EDUCATION DAY, June 4 2014
  • 29. Generation of Submission Ready Documents 29 CAPRA EDUCATION DAY, June 4 2014 Generation of submission ready documents in conjunction with completion of development activities
  • 30. Generation of Submission Ready Documents Global regulatory strategy does not mean identical processes or documentation  Obtain and manage documents during development  Critical for timely application of guidelines/unique or national requirements during development  Important for introduction of standard practices for document generation, review and tracking  Key to successful submission, review and outcome 30 CAPRA EDUCATION DAY, June 4 2014 Generation of submission ready documents in conjunction with completion of development activities
  • 31. Regulatory Submissions Simplistic Success Formula CAPRA EDUCATION DAY, June 4 2014 31  Know the regulations, guidelines and specific requirements  Develop quality data using appropriate GMP, GCP, GLP, QSR and QbD requirements  Have well trained staff at all levels  Build and maintain strong communication links with the regulatory authority before and during the review process  Submit a well written dossier  Plan for all post-approval commitments
  • 32. CAPRA EDUCATION DAY, June 4 2014 32 Questions ? Thank You